MAPT and Parkinson disease: Regarding tau, AD patients demonstrated decreased levels of anti-tau IgG compared to PD (p < 0.005) patients (Fig. 2G; Table 3), whereas AD patients had increased levels of anti-tau IgA compared to DLB patient (p = 0.011).